Another study investigating biomarker differences across different ethnicities reported elevated plasma YKL-40 concentrations specifically in Hispanic women with prodromal AD compared to both CU controls and prodromal AD participants of African or Caucasian origins. This evidence concerns the gene CHI3L1 and Alzheimer disease.